申请人:The Regents of the University of California
公开号:US20210238145A1
公开(公告)日:2021-08-05
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.